Role of microRNAs in lymphoid biology and disease
- 1 July 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 18 (4), 266-272
- https://doi.org/10.1097/moh.0b013e3283476012
Abstract
This review provides a state-of-the-art knowledge on the implications of microRNA (miRNA) dysregulation in lymphoid malignancies. Several new studies have broadened our understanding of how aberrations of the miRNome contribute to the development of a malignant lymphoid phenotype. Recently, a new pathogenetic model involving miRNAs and protein coding genes (such as TP53 and ZAP-70) has been identified and explains the prognostic implications of the most recurrent chromosomal abnormalities in human B-cell chronic lymphocytic leukemia. Moreover, new recent studies have addressed the role of miRNAs in human lymphomas and acute lymphoblastic leukemias. The recent advances in our understanding of the role of miRNAs in lymphoid malignancies demonstrate that miRNAs can effectively be used as tumoral biomarkers with implications for diagnosis, prognosis, and prediction of response to therapy.Keywords
This publication has 68 references indexed in Scilit:
- Myc overexpression brings out unexpected antiapoptotic effects of miR-34aOncogene, 2011
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic LeukemiaJAMA, 2011
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytesNature Immunology, 2008
- MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemiaProceedings of the National Academy of Sciences, 2007
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphomaInternational Journal of Cancer, 2007
- B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemiaProceedings of the National Academy of Sciences, 2006
- Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic miceProceedings of the National Academy of Sciences, 2006
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005